🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ling Duan

Translational Therapeutics (United States)

ORCID: 0009-0006-3884-0808
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol”.

AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0235
N/A
0DataRank · unranked
11 citations

Clementina Mesaros, Ling Duan, T.M. Penning, Andrea J. Detlefsen

Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00732
N/A
0DataRank · unranked
10 citations

Sravan K. Jonnalagadda, Ahmed Morsy, Ling Duan, Yashpal S. Chhonker, Daryl J. Murry +3 more

Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader

Communications Chemistry(2024)10.1038/s42004-024-01177-4
N/A
0DataRank · unranked
13 citations

Shirisha Jonnalagadda, Alfie M. Case, Maddeboina Krishnaiah, Sravan K. Jonnalagadda, Louise F. Dow +4 more

Coumarin‐Based Aldo‐Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors

ChemMedChem(2024)10.1002/cmdc.202400081
N/A
0DataRank · unranked
4 citations

Ling Duan, Louise F. Dow, Geetha P. Boligala, Elizabeth A. Kosmacek, Kristyn McCoy +8 more